ATH
Click for more information
10.0% 0.5¢ alterity therapeutics limited

Research AD biomarkers to routine diagnostics, page-5

  1. m123456
    1,639 Posts.
    lightbulb Created with Sketch. 143
    clock Created with Sketch.
    15/03/21
    11:26
    Post #: 51768287
    ?? Pbt2 is worth way more than 3c or 4c a share. Why would alteriry sell it? I bet it they did it would be straight back into trials for AD and the dog concerns would disappear
    Last edited by m123456: 15/03/21
    ATH Price at posting: 3.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
-0.001(10.0%) 		Mkt cap ! $23.60M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $17.8K 3.6M

Buyers (Bids)

No. Vol. Price($)
66 75025101 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 27379258 24
View Market Depth
Last trade - 10.32am 27/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.